PMID- 23342086 OWN - NLM STAT- MEDLINE DCOM- 20130802 LR - 20220616 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 1 DP - 2013 TI - The adipocytokine Nampt and its product NMN have no effect on beta-cell survival but potentiate glucose stimulated insulin secretion. PG - e54106 LID - 10.1371/journal.pone.0054106 [doi] LID - e54106 AB - AIMS/HYPOTHESIS: Obesity is associated with a dysregulation of beta-cell and adipocyte function. The molecular interactions between adipose tissue and beta-cells are not yet fully elucidated. We investigated, whether or not the adipocytokine Nicotinamide phosphoribosyltransferase (Nampt) and its enzymatic product Nicotinamide mononucleotide (NMN), which has been associated with obesity and type 2 diabetes mellitus (T2DM) directly influence beta-cell survival and function. METHODS: The effect of Nampt and NMN on viability of INS-1E cells was assessed by WST-1 assay. Apoptosis was measured by Annexin V/PI and TUNEL assay. Activation of apoptosis signaling pathways was evaluated. Adenylate kinase release was determined to assess cytotoxicity. Chronic and acute effects of the adipocytokine Nampt and its enzymatic product NMN on insulin secretion were assessed by glucose stimulated insulin secretion in human islets. RESULTS: While stimulation of beta-cells with the cytokines IL-1beta, TNFalpha and IFN-gamma or palmitate significantly decreased viability, Nampt and NMN showed no direct effect on viability in INS-1E cells or in human islets, neither alone nor in the presence of pro-diabetic conditions (elevated glucose concentrations and palmitate or cytokines). At chronic conditions over 3 days of culture, Nampt and its product NMN had no effects on insulin secretion. In contrast, both Nampt and NMN potentiated glucose stimulated insulin secretion acutely during 1 h incubation of human islets. CONCLUSION/INTERPRETATION: Nampt and NMN neither influenced beta-cell viability nor apoptosis but acutely potentiated glucose stimulated insulin secretion. FAU - Spinnler, Robert AU - Spinnler R AD - Center for Pediatric Research Leipzig-CPL, Department for Women and Child Health, University of Leipzig, Leipzig, Germany. FAU - Gorski, Theresa AU - Gorski T FAU - Stolz, Katharina AU - Stolz K FAU - Schuster, Susanne AU - Schuster S FAU - Garten, Antje AU - Garten A FAU - Beck-Sickinger, Annette G AU - Beck-Sickinger AG FAU - Engelse, Marten A AU - Engelse MA FAU - de Koning, Eelco J P AU - de Koning EJ FAU - Korner, Antje AU - Korner A FAU - Kiess, Wieland AU - Kiess W FAU - Maedler, Kathrin AU - Maedler K LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130116 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Adiponectin) RN - 0 (Insulin) RN - 0 (Leptin) RN - EC 2.4.2.12 (Nicotinamide Phosphoribosyltransferase) RN - IY9XDZ35W2 (Glucose) SB - IM EIN - PLoS One. 2022 Jun 16;17(6):e0270243. PMID: 35709079 MH - Adiponectin/metabolism MH - Animals MH - Apoptosis/drug effects MH - Blotting, Western MH - Cell Survival/drug effects MH - Glucose/pharmacology MH - Humans MH - Insulin/metabolism MH - Insulin Secretion MH - Insulin-Secreting Cells/*drug effects/*metabolism MH - Leptin/metabolism MH - Nicotinamide Phosphoribosyltransferase/*pharmacology MH - Rats PMC - PMC3546920 COIS- Competing Interests: The authors would also like to confirm that Kathrin Madler is co-author of this manuscript and a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. EDAT- 2013/01/24 06:00 MHDA- 2013/08/03 06:00 PMCR- 2013/01/16 CRDT- 2013/01/24 06:00 PHST- 2012/06/28 00:00 [received] PHST- 2012/12/10 00:00 [accepted] PHST- 2013/01/24 06:00 [entrez] PHST- 2013/01/24 06:00 [pubmed] PHST- 2013/08/03 06:00 [medline] PHST- 2013/01/16 00:00 [pmc-release] AID - PONE-D-12-20262 [pii] AID - 10.1371/journal.pone.0054106 [doi] PST - ppublish SO - PLoS One. 2013;8(1):e54106. doi: 10.1371/journal.pone.0054106. Epub 2013 Jan 16.